Avidan M S, Alcock E L, Da Fonseca J, Ponte J, Desai J B, Despotis G J, Hunt B J
Department of Anesthesiology, Washington University School of Medicine, St Louis, MO 63110, USA.
Br J Anaesth. 2004 Feb;92(2):178-86. doi: 10.1093/bja/aeh037.
Using algorithms based on point of care coagulation tests can decrease blood loss and blood component transfusion after cardiac surgery. We wished to test the hypothesis that a management algorithm based on near-patient tests would reduce blood loss and blood component use after routine coronary artery surgery with cardiopulmonary bypass when compared with an algorithm based on routine laboratory assays or with clinical judgement.
Patients (n=102) undergoing elective coronary artery surgery with cardiac bypass were randomized into two groups. In the point of care group, the management algorithm was based on information provided by three devices, the Hepcon, thromboelastography and the PFA-100 platelet function analyser. Management in the laboratory test group depended on rapidly available laboratory clotting tests and transfusion of haemostatic blood components only if specific criteria were met. Blood loss and transfusion was compared between these two groups and with a retrospective case-control group (n=108), in which management of bleeding had been according to the clinician's discretion.
All three groups had similar median blood losses. The transfusion of packed red blood cells (PRBCs) and blood components was greater in the clinician discretion group (P<0.05) but there was no difference in the transfusion of PRBCs and blood components between the two algorithm-guided groups.
Following algorithms based on point of care tests or on structured clinical practice with standard laboratory tests does not decrease blood loss, but reduces the transfusion of PRBCs and blood components after routine cardiac surgery, when compared with clinician discretion. Cardiac surgery services should use transfusion guidelines based on laboratory-guided algorithms, and the possible benefits of point of care testing should be tested against this standard.
使用基于即时凝血检测的算法可减少心脏手术后的失血和血液成分输血。我们希望检验这一假设:与基于常规实验室检测或临床判断的算法相比,基于床旁检测的管理算法能减少常规体外循环冠状动脉搭桥术后的失血和血液成分使用。
102例接受择期体外循环冠状动脉搭桥手术的患者被随机分为两组。在床旁检测组,管理算法基于三种设备(Hepcon、血栓弹力图仪和PFA - 100血小板功能分析仪)提供的信息。实验室检测组的管理取决于快速可得的实验室凝血检测结果,且仅在满足特定标准时才输注止血血液成分。比较这两组之间以及与一个回顾性病例对照组(n = 108)的失血量和输血量,病例对照组的出血管理由临床医生自行决定。
所有三组的中位失血量相似。临床医生自行决定组的浓缩红细胞(PRBCs)和血液成分输注量更大(P<0.05),但两个算法指导组之间的PRBCs和血液成分输注量没有差异。
与临床医生自行决定相比,遵循基于床旁检测的算法或基于标准实验室检测的结构化临床实践算法,虽不会减少常规心脏手术后的失血量,但会减少PRBCs和血液成分的输注。心脏手术服务应使用基于实验室指导算法的输血指南,且应以此标准检验床旁检测的潜在益处。